Researchers Dose First Patient in Pivotal Study of Duvelisib

The study is evaluating the oral inhibitor for patients with relapsed or refractory follicular  lymphoma.

Source: CancerNetwork - February 7, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news